Pilot Study Shows Scarguard Effective In Minimizing Scars
Study Conducted In Response To Overwhelming Change Of Post-Operative Scar Care By Plastic Surgeons Confirms Scarguard® ScarCare® Efficacy*
Great Neck, NY - In response to the large numbers of surgeons using this breakthrough scar treatment, dermatologist Drore Eisen, MD, DDS, created an open-label pilot study of 12 patients with a history of keloid and hypertrophic scar formation to determine if Scarguard ScarCare is effective at preventing scars after a surgical procedure. After two months of therapy, nine out of twelve patients reported superior outcomes using Scarguard ScarCare.
Scarguard ScarCare, the OTC scar treatment most recommended by plastic surgeons, combines the five key elements shown in past studies to have varying degrees of effectiveness in improving the healing of scars: pressure, occlusion, silicone, corticosteroids and vitamin E. This new, topical scar treatment combines silicone, hydrocortisone, and vitamin E in a clear liquid that brushes on, dries quickly and forms a clear protective film over the wound. The flexible film carrier adds occlusion and slight increased surface tension effectively delivering all the treatment modalities shown to get results in one, easy-to-apply product. Because it is invisible, dries quickly and doesn't wash off with water, Scarguard overcomes the compliance issue that has been problematic for competitive patches and gels.
"Scarguard's multi-modal treatment offers real results, setting it apart from other products on the market," said Joel Studin, M.D., F.A.C.S., inventor of Scarguard ScarCare and Chairman and CEO of Red Rock Laboratories, LLC and a plastic and reconstructive surgeon.
According to Eisen's study, anecdotal evidence suggests this product stimulates the production of endogenous collagenase which helps the body to heal itself warranting further investigation to confirm these results.
Methodology
In this study, participating patients had two moles removed by shave excision. All patients were instructed to apply a topical antibiotic ointment to both surgical wounds until they were completely healed. Once healed, one wound was treated with Scarguard ScarCare, the other was left to heal without any treatment and served as the control. Patients continued this treatment for two months. Patients and the investigator evaluated the surgical wounds based on color, contour, texture and overall appearance. Nine out of 12 reported the Scarguard ScarCare treated wound was less red and noticeable than the control wound. Half of those studied found their treated scars to be less raised and softer than the control wound. The Scarguard ScarCare formula offers patients an effective alternative to therapeutic options such as painful intralesional corticosteroid injections and surgical excision.
"We are excited about the results of this study and are more convinced than ever that the combination of ingredients in Scarguard, coupled with this innovative delivery system, offer the breakthrough in efficacy that gives patients and their doctors the best possible outcome, both after surgery and on old overgrown scars," said Studin.
Dr. Joel Studin, in partnership with Red Rock Laboratories, LLC developed Scarguard ScarCare in 1998 and Scarguard Lightener in 2001 to help improve the final outcome of surgical procedures and help improve the appearance of existing hypertrophic and darkened scars. The privately held company has been distributing Scarguard ScarCare and Scarguard Lightener in partnership with Mentor Corporation (NYSE:MENT) through plastic surgeons since the products first became available and has received overwhelmingly positive response from both doctors and their patients. For more information, visit www.scarguard.com or call (877) SCARGUARD.
Representatives from Scarguard will be at the Mentor Booth (#929) at the American Society of Plastic Surgeons Annual Scientific Meeting in Philadelphia at the Pennsylvania Convention Center from October 10-12.
* Based on customer survey of plastic surgeons conducted August 2004 by Byron Medical Division of Mentor Corp.
Drore Eisen: A Pilot Study to Evaluate the Efficacy of Scarguard in the Prevention of Scars. The Internet Journal of Dermatology. 2004. Volume 5 Number 2.
Source: Red Rock Laboratories, LLC